Initial treatment approaches for nodular gastric antral vascular ectasia: A comparison of endoscopic band ligation and thermal therapies

Table 4 Comparison of patient characteristics between initial endoscopic band and initial endoscopic thermal therapy

	Initial EBL	Initial ETT	P value
Number	21	16
Age	63.6	59.1	0.343
Gender			0.751
Female	43%	31%
Male	57%	69%
Race/ethnicity			0.486
Non-Hispanic white	90%	88%
Non-Hispanic black	5%	12%
Latino	5%	0%
Other	0%	0%
MELD
Pre-treatment	14.9	14	0.531
Post-treatment	13.8	13.4	0.660
Etiology			0.639
MASLD/MASH	62%	50%
EtOH cirrhosis	33%	31%
Other	5%	19%
Comorbidities
Hyperlipidemia	29%	44%	0.359
Chronic kidney disease	14%	19%	0.669
BMI	34.7	32.8	0.778
Hemoglobin A1c	5.86	5.88	0.952
Medications
Proton pump inhibitor
Oral	95%	100%	0.329
Anticoagulation	5%	0%	0.329
Antiplatelet	29%	6%	0.069

EBL: Endoscopic band ligation; ETT: Endoscopic thermal therapy; MELD: Model for end-stage liver disease; MASLD: Metabolic dysfunction-associated steatotic liver disease; MASH: Metabolic dysfunction-associated steatohepatitis; EtOH cirrhosis: Alcohol-associated cirrhosis; BMI: Body mass index.